Phase I/II Study of DC Vaccine Targeting MG-7 Antigen to Treat Gastric Cancer
The primary purpose of the study is to determine the safety and efficacy of autologous DC vaccine in patients with later stage of gastric cancer. The DC vaccine is gene modified with gastric cancer specific antigen MG-7.
100 Clinical Results associated with Shandong Sunstem Biotechnology Co., Ltd.
0 Patents (Medical) associated with Shandong Sunstem Biotechnology Co., Ltd.
100 Deals associated with Shandong Sunstem Biotechnology Co., Ltd.
100 Translational Medicine associated with Shandong Sunstem Biotechnology Co., Ltd.